CLARI — Clariane SE Share Price
0.000.00%
Last trade - 00:00- €1.14bn
- €8.91bn
- €5.28bn
- 40
- 95
- 93
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.61 | ||
| PEG Ratio (f) | 0.17 | ||
| EPS Growth (f) | 9,684.38% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.31 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 1.93 | ||
| Price to Sales | 0.22 | ||
| EV to EBITDA | 8.89 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.31% | ||
| Return on Equity | -0.83% | ||
| Operating Margin | 4.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 3,772.91 | 4,137.31 | 4,438.3 | 4,995.58 | 5,281.76 | 5,539.33 | 5,818.33 | 7.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -65.74 | +209.34 | -44.98 | -91.29 | n/a | n/a | +183.82 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clariane SE, formerly Korian SE, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy, Belgium and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
Directors
- Jean-Pierre Duprieu NEC (69)
- Sophie Boissard CEO (50)
- Philippe Garin CFO
- Remi Boyer CHO
- Frederic Durousseau VBD
- Didier Armaingaud EXB
- Dominiek Beelen EXB
- Bart Bots EXB
- Caroline De Jessey EXB (55)
- Anne-Charlotte Dymny EXB
- Federico Guidoni EXB
- Nicolas Merigot EXB
- Charles-Antoine Pinel EXB
- Mariuccia Rossini EXB
- Arno Schwalie EXB
- Francoise Debrus DRC (61)
- Philippe Dumont DRC (61)
- Marie-Christine Leroux DRC (60)
- Anne Ramon DRC (53)
- Markus Rueckerl DRC (47)
- Guillaume Bouhours IND (45)
- Jean-Francois Brin IND (56)
- Anne Lalou IND (57)
- Markus Mueschenich IND (59)
- Catherine Soubie IND (55)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 12th, 2003
- Public Since
- November 23rd, 2006
- No. of Employees
- 61,798
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 319,792,193
- Address
- 21 - 25 rue Balzac, PARIS, 75008
- Web
- https://www.korian.fr/
- Phone
- +33 155375200
- Contact
- Stephane Bisseuil
- Auditors
- Ernst & Young et Autres
Upcoming Events for CLARI
Clariane SE Annual Shareholders Meeting
Half Year 2025 Clariane SE Earnings Release
Q3 2025 Clariane SE Corporate Sales Release
Similar to CLARI
Bastide le Confort Medical SA
Euronext - Paris
Emeis SA
Euronext - Paris
Klea Holding
Euronext - Paris
LNA Sante SA
Euronext - Paris
Ramsay Generale De Sante SA
Euronext - Paris
FAQ
What is the Clariane SE share price?
As of Today at 19:58 UTC, shares in Clariane SE are trading at €3.58. This share price information is delayed by 15 minutes.
How has the Clariane SE share price performed this year?
Shares in Clariane SE last closed at €3.58 and the price had moved by +262.2% over the past 365 days. In terms of relative price strength the Clariane SE share price has outperformed the FTSE Global All Cap Index by +253.14% over the past year.
What are the analyst and broker recommendations for Clariane SE?
The overall consensus recommendation for Clariane SE is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clariane SE dividend yield?
Clariane SE does not currently pay a dividend.
Does Clariane SE pay a dividend?
Clariane SE does not currently pay a dividend.
When does Clariane SE next pay dividends?
Clariane SE does not currently pay a dividend.
How do I buy Clariane SE shares?
To buy shares in Clariane SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clariane SE?
As of the previous close price of €3.58, shares in Clariane SE had a market capitalisation of €1.14bn.
Where are Clariane SE shares listed?
Here are the trading details for Clariane SE:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: CLARI
What kind of share is Clariane SE?
Based on an overall assessment of its quality, value and momentum Clariane SE is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clariane SE share price forecast for 2025?
The analyst consensus target price for shares in Clariane SE is €2.70. That is 24.54% below the last closing price of €3.58.
Analysts covering Clariane SE currently have a consensus Earnings Per Share (EPS) forecast of €0.14 for the next financial year.
Find out moreWhat is the trend in the Clariane SE share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clariane SE. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +86.99%.
As of the last closing price of €3.58, shares in Clariane SE were trading +51.43% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clariane SE PE Ratio?
The Clariane SE PE ratio based on its reported earnings over the past 12 months is 16.61. The shares last closed at €3.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clariane SE?
Clariane SE's management team is headed by:
- Jean-Pierre Duprieu - NEC
- Sophie Boissard - CEO
- Philippe Garin - CFO
- Remi Boyer - CHO
- Frederic Durousseau - VBD
- Didier Armaingaud - EXB
- Dominiek Beelen - EXB
- Bart Bots - EXB
- Caroline De Jessey - EXB
- Anne-Charlotte Dymny - EXB
- Federico Guidoni - EXB
- Nicolas Merigot - EXB
- Charles-Antoine Pinel - EXB
- Mariuccia Rossini - EXB
- Arno Schwalie - EXB
- Francoise Debrus - DRC
- Philippe Dumont - DRC
- Marie-Christine Leroux - DRC
- Anne Ramon - DRC
- Markus Rueckerl - DRC
- Guillaume Bouhours - IND
- Jean-Francois Brin - IND
- Anne Lalou - IND
- Markus Mueschenich - IND
- Catherine Soubie - IND